| pubmed-article:9101988 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9101988 | lifeskim:mentions | umls-concept:C0007121 | lld:lifeskim |
| pubmed-article:9101988 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:9101988 | lifeskim:mentions | umls-concept:C1514474 | lld:lifeskim |
| pubmed-article:9101988 | pubmed:dateCreated | 1997-4-17 | lld:pubmed |
| pubmed-article:9101988 | pubmed:abstractText | Between 1 Jan 1984-1 Jan 1990, 199 patients underwent curative (R0) surgery for non-small cell lung cancer. The pathohistological findings showed that a carcinomatous lymphangiosis and haemangiosis (L/H pos.) were present in 26 patients. In six patients, no lymph node metastases were detected. The median (22 mo. vs. 74 mo.) and 5-year survival (25% vs. 41%) were significantly (p < 0.001) higher compared to patients with and without lymphangiosis and haemangiosis carcinomatosa (L/H neg.). There were also significant (p < 0.05) differences in the survival time between pNO L/H neg. and pNO L/H pos. patients (median 74 mo. vs. 15 mo.-5 years 43% vs. 0%). | lld:pubmed |
| pubmed-article:9101988 | pubmed:language | ger | lld:pubmed |
| pubmed-article:9101988 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9101988 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9101988 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9101988 | pubmed:issn | 0942-2854 | lld:pubmed |
| pubmed-article:9101988 | pubmed:author | pubmed-author:MeyerWW | lld:pubmed |
| pubmed-article:9101988 | pubmed:author | pubmed-author:GebhardtCC | lld:pubmed |
| pubmed-article:9101988 | pubmed:author | pubmed-author:BaumannMM | lld:pubmed |
| pubmed-article:9101988 | pubmed:author | pubmed-author:SchultheisK... | lld:pubmed |
| pubmed-article:9101988 | pubmed:author | pubmed-author:MittelmeierH... | lld:pubmed |
| pubmed-article:9101988 | pubmed:author | pubmed-author:WünschPP | lld:pubmed |
| pubmed-article:9101988 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9101988 | pubmed:volume | 113 | lld:pubmed |
| pubmed-article:9101988 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9101988 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9101988 | pubmed:pagination | 775-8 | lld:pubmed |
| pubmed-article:9101988 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:meshHeading | pubmed-meshheading:9101988-... | lld:pubmed |
| pubmed-article:9101988 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:9101988 | pubmed:articleTitle | [Lymph- and haemangiosis carcinomatosa--an important prognostic factor in non-small-cell bronchial carcinoma (NSCLC)]. | lld:pubmed |
| pubmed-article:9101988 | pubmed:affiliation | Klinik für Viszeral-, Thorax- und Endokrine Chirurgie, Städtisches Klinikum Nürnberg Nord. | lld:pubmed |
| pubmed-article:9101988 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9101988 | pubmed:publicationType | English Abstract | lld:pubmed |
